Immuneering Corporation
IMRX
Positions held
Your positionsIMRX isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $241.97M | Enterprise value | $95.70M | Trailing P/E | — | Forward P/E | -2.98 |
| PEG | — | Price / book | 1.27 | Beta | 0.46 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -52.1% | ROA | -32.8% | Debt / equity | 0.02 |
| Current ratio | 19.47 | Free cash flow | -$39.35M | Analyst recommendation | strong_buy | Mean target | $17.17 |
| 52w high | $8.48 | 52w low | $3.60 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — | — | — |
| Net income | -$17.3M | -$13.5M | -$11.6M | -$15.0M | -$14.4M |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$19.0M | -$15.3M | -$13.8M | -$15.4M | -$14.8M |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.3M | — |
| Op margin | — | — | — | -16325.9% | — |
| Net income | -$56.0M | -$61.0M | -$53.5M | -$50.5M | — |
| Gross margin | — | — | — | 50.1% | — |
| Gross profit | — | — | $0.0M | $0.2M | $0.9M |
| Operating income | -$59.4M | -$64.1M | -$58.4M | -$51.7M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-02 · Immuneering to Present at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
2026-09-24 · Immuneering to Present at the ESMO Congress 2026
2026-09-03 · Immuneering to Participate in Upcoming Investor Conferences
2026-08-06 · Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls
2026-08-06 · HC Wainwright Initiates Immuneering at Buy With $14 Price Target
2026-08-05 · Immuneering Reports Second Quarter 2026 Financial Results and Provides Business Updates
2026-07-17 · Immuneering Corporation Announces Grants of Inducement Awards
2026-07-15 · Immuneering (IMRX) Upgraded to Buy: Here's What You Should Know
Price (daily)
Full chart · RSI · MACD · patterns